New Publication in Vaccine Highlights Preclinical Results of Vaxart's Mucosal Chikungunya Vaccine - Odessa American

New Publication in Vaccine Highlights Preclinical Results of Vaxart's Mucosal Chikungunya Vaccine  Odessa American

Vaxart, Inc. (Nasdaq: VXRT), a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by ...